2008
DOI: 10.1016/j.ghir.2008.01.003
|View full text |Cite
|
Sign up to set email alerts
|

Contrasting bone effects of temporary versus permanent IGFBP administration in rodents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7

Relationship

4
3

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 49 publications
1
4
0
Order By: Relevance
“…Increase of IGFBP2 has been shown to delay development in fetuses and reduce BW and skeleton growth (Tapanainen et al, 1994;Hoeflich, 2008), and also impair IGF-1 promotion of mammary gland development (Hadsell et al, 1996;Wolf et al, 1997). Coincidentally, in our study, high immunolabeling of IGFBP2 in untreated heifers was related with lower development of the parenchyma (Perri et al, 2013) and also a lower rate of cell division.…”
Section: Discussionsupporting
confidence: 70%
“…Increase of IGFBP2 has been shown to delay development in fetuses and reduce BW and skeleton growth (Tapanainen et al, 1994;Hoeflich, 2008), and also impair IGF-1 promotion of mammary gland development (Hadsell et al, 1996;Wolf et al, 1997). Coincidentally, in our study, high immunolabeling of IGFBP2 in untreated heifers was related with lower development of the parenchyma (Perri et al, 2013) and also a lower rate of cell division.…”
Section: Discussionsupporting
confidence: 70%
“…While the role of IGFBPs in other tissues such as bone is relatively well understood [18][19][20][21], there is a dearth of information regarding the role of IGFBPs in skeletal muscle, particularly in the pathophysiology of muscular dystrophy. Of the IGFBP family, only IGFBP-5 has been directly investigated in muscular dystrophy, with increased expression in DMD fibroblasts correlating with impaired DMD myoblast growth in vitro [22].…”
Section: Introductionmentioning
confidence: 99%
“…Increased serum IGFBP-2 concentrations have been correlated with low body weight in male mice [18]. Furthermore, mice with systemic over-expression of IGFBP-2 are significantly smaller than their non-transgenic littermates and have smaller myofibers [27,29,33].…”
Section: Introductionmentioning
confidence: 99%
“…The longer-term inhibitory effects of soluble IGFBP2 (e.g., on cell proliferation [13]) can be neglected in the new bioassay. IGFBP effects as a function of the duration of IGFBP exposure were also discussed in vivo [20]. Notably, insulin-stimulated AKT phosphorylation at supraphysiological concentrations and preincubation with IGFBP2 did not affect insulin sensitivity in our system.…”
Section: Short-term Effects Of Membrane-bound Igfbp2 Vs Longer-term mentioning
confidence: 72%